RGNX
Price
$9.01
Change
+$0.19 (+2.15%)
Updated
Aug 28 closing price
Capitalization
455.13M
68 days until earnings call
VYGR
Price
$3.40
Change
-$0.02 (-0.58%)
Updated
Aug 28 closing price
Capitalization
188.59M
81 days until earnings call
Interact to see
Advertisement

RGNX vs VYGR

Header iconRGNX vs VYGR Comparison
Open Charts RGNX vs VYGRBanner chart's image
REGENXBIO
Price$9.01
Change+$0.19 (+2.15%)
Volume$445.57K
Capitalization455.13M
Voyager Therapeutics
Price$3.40
Change-$0.02 (-0.58%)
Volume$295.46K
Capitalization188.59M
RGNX vs VYGR Comparison Chart in %
Loading...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RGNX vs. VYGR commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGNX is a Hold and VYGR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (RGNX: $9.01 vs. VYGR: $3.40)
Brand notoriety: RGNX and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RGNX: 67% vs. VYGR: 40%
Market capitalization -- RGNX: $455.13M vs. VYGR: $188.59M
RGNX [@Biotechnology] is valued at $455.13M. VYGR’s [@Biotechnology] market capitalization is $188.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RGNX’s FA Score shows that 0 FA rating(s) are green whileVYGR’s FA Score has 1 green FA rating(s).

  • RGNX’s FA Score: 0 green, 5 red.
  • VYGR’s FA Score: 1 green, 4 red.
According to our system of comparison, VYGR is a better buy in the long-term than RGNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RGNX’s TA Score shows that 7 TA indicator(s) are bullish while VYGR’s TA Score has 4 bullish TA indicator(s).

  • RGNX’s TA Score: 7 bullish, 3 bearish.
  • VYGR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RGNX is a better buy in the short-term than VYGR.

Price Growth

RGNX (@Biotechnology) experienced а +11.10% price change this week, while VYGR (@Biotechnology) price change was +1.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.14%. For the same industry, the average monthly price growth was +15.09%, and the average quarterly price growth was +29.14%.

Reported Earning Dates

RGNX is expected to report earnings on Nov 05, 2025.

VYGR is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (-1.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGNX($455M) has a higher market cap than VYGR($189M). RGNX YTD gains are higher at: 16.559 vs. VYGR (-40.035). VYGR has higher annual earnings (EBITDA): -119.18M vs. RGNX (-129.93M). RGNX has more cash in the bank: 323M vs. VYGR (43.9M). VYGR has less debt than RGNX: VYGR (40.2M) vs RGNX (77.7M). RGNX has higher revenues than VYGR: RGNX (156M) vs VYGR (42.6M).
RGNXVYGRRGNX / VYGR
Capitalization455M189M241%
EBITDA-129.93M-119.18M109%
Gain YTD16.559-40.035-41%
P/E RatioN/A6.00-
Revenue156M42.6M366%
Total Cash323M43.9M736%
Total Debt77.7M40.2M193%
FUNDAMENTALS RATINGS
RGNX vs VYGR: Fundamental Ratings
RGNX
VYGR
OUTLOOK RATING
1..100
719
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
29
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5560
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VYGR's Valuation (29) in the Biotechnology industry is somewhat better than the same rating for RGNX (71). This means that VYGR’s stock grew somewhat faster than RGNX’s over the last 12 months.

VYGR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as RGNX (100). This means that VYGR’s stock grew similarly to RGNX’s over the last 12 months.

VYGR's SMR Rating (100) in the Biotechnology industry is in the same range as RGNX (100). This means that VYGR’s stock grew similarly to RGNX’s over the last 12 months.

RGNX's Price Growth Rating (55) in the Biotechnology industry is in the same range as VYGR (60). This means that RGNX’s stock grew similarly to VYGR’s over the last 12 months.

RGNX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as VYGR (100). This means that RGNX’s stock grew similarly to VYGR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RGNXVYGR
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 8 days ago
77%
Bullish Trend 8 days ago
79%
Declines
ODDS (%)
Bearish Trend 12 days ago
84%
Bearish Trend 10 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EVSTX22.59N/A
N/A
Allspring Disciplined US Core C
FWOAX17.95N/A
N/A
Fidelity Advisor Women's Leadership A
LASGX16.27N/A
N/A
Lord Abbett International Growth R4
HQIIX21.63N/A
N/A
Hartford Equity Income I
IGHAX12.53N/A
N/A
Voya Global High Dividend Low Vol Port A

RGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGNX has been loosely correlated with SYRE. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if RGNX jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGNX
1D Price
Change %
RGNX100%
+2.15%
SYRE - RGNX
55%
Loosely correlated
-2.45%
DNLI - RGNX
53%
Loosely correlated
+0.32%
MGNX - RGNX
53%
Loosely correlated
-1.16%
ARWR - RGNX
53%
Loosely correlated
+2.52%
KYMR - RGNX
53%
Loosely correlated
-1.21%
More

VYGR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with RGNX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
-0.58%
RGNX - VYGR
52%
Loosely correlated
+2.15%
KYMR - VYGR
50%
Loosely correlated
-1.21%
XNCR - VYGR
49%
Loosely correlated
+0.37%
XENE - VYGR
47%
Loosely correlated
-0.69%
TRDA - VYGR
46%
Loosely correlated
-0.53%
More